Stem cell transplant for multiple sclerosis (MS) has been a subject of great interest to scientists, physicians, and patients. The status of stem cell therapy is a common question posed by patients at their annual MS visit, usually as a parting query. Most patients have a vague concept of stem cell therapy, typically one that has been molded by a perception that stem cell therapy is regenerative. Therapies that promote regeneration of lost myelin and axons are all but absent from the current armamentarium of neurologists.
Paz Soldán MM, Weinshenker BG. Moving Targets for Hematopoietic Stem Cell Transplantation for Multiple Sclerosis. JAMA Neurol. 2015;72(2):147–149. doi:10.1001/jamaneurol.2014.3831
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: